The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes patients towards higher priced insulin.

CVS Caremark and Optum disputed the FTC's allegations. "CVS Caremark is proud of the work we have done to make insulin more affordable for all Americans with diabetes.

Express Scripts, CVS Caremark and OptumRx together control 59.2% of the pharmacy benefits market, according to data the American Medical Association published this month. Other reports indicate ...

FTC halts case against CVS Caremark, OptumRx. Story by Tina Reed • 1w. T he Trump administration has paused the Federal Trade Commission's lawsuit against major pharmacy benefit managers after ...

Cigna, UnitedHealth and CVS Caremark are calling Federal Trade Commission (FTC) Chair Lina Khan and two other commissioners to either recuse themselves, or be removed from the agency’s lawsuit ...

FTC sues major pharmacy benefit managers over insulin prices The agency brought action against Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating ...

The Federal Trade Commission has sued CVS Caremark, Express Scripts and Optum Rx, alleging that they engage in "anticompetitive and unfair rebating practices” as it relates to insulin.

Cigna, UnitedHealth and CVS Caremark are calling Federal Trade Commission (FTC) Chair Lina Khan and two other commissioners to either recuse themselves, or be removed from the agency’s lawsuit ...

A CVS Caremark official said the FTC did not allow them to preview the report. Related. Big 3 PBMs want Lina Khan off the FTC insulin lawsuit “Our clients, not CVS Caremark, ...

From 2017 to 2022, the companies — UnitedHealth Group's UNH.N Optum, CVS Health's CVS.N CVS Caremark and Cigna's CI.N Express Scripts — marked up prices at their pharmacies by hundreds or ...